Nifty
Sensex
:
:
24800.85
81343.46
187.85 (0.76%)
626.91 (0.78%)

Pharmaceuticals & Drugs

Rating :
56/99

BSE: 524470 | NSE: SYNCOMF

12.84
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  12.68
  •  13.05
  •  12.61
  •  12.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3598227
  •  461.68
  •  18.65
  •  7.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,430.68
  • 56.52
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,435.30
  • N/A
  • 4.97

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.57%
  • 1.28%
  • 44.85%
  • FII
  • DII
  • Others
  • 0.08%
  • 0.00%
  • 3.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.01
  • 3.76
  • -2.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.03
  • 10.92
  • -12.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.97
  • 12.60
  • -11.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.04
  • 46.24
  • 61.45

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.89
  • 0.90
  • 1.50

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.60
  • 25.66
  • 36.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
74.57
60.98
22.29%
65.14
57.38
13.52%
63.84
54.49
17.16%
59.84
51.40
16.42%
Expenses
65.15
55.02
18.41%
57.78
51.48
12.24%
57.43
50.21
14.38%
53.38
47.91
11.42%
EBITDA
9.42
5.96
58.05%
7.36
5.91
24.53%
6.41
4.28
49.77%
6.46
3.48
85.63%
EBIDTM
12.64%
9.77%
11.30%
10.29%
10.04%
7.86%
10.80%
6.78%
Other Income
3.10
6.77
-54.21%
4.55
1.98
129.80%
4.00
2.87
39.37%
1.88
2.98
-36.91%
Interest
1.19
1.29
-7.75%
1.08
0.72
50.00%
1.08
0.62
74.19%
1.12
0.50
124.00%
Depreciation
1.30
1.17
11.11%
1.45
1.20
20.83%
0.88
1.18
-25.42%
1.10
0.99
11.11%
PBT
10.03
10.28
-2.43%
9.36
5.96
57.05%
8.45
5.36
57.65%
6.11
4.97
22.94%
Tax
2.63
1.81
45.30%
2.36
1.82
29.67%
1.94
1.77
9.60%
1.72
1.10
56.36%
PAT
7.40
8.47
-12.63%
7.00
4.15
68.67%
6.51
3.59
81.34%
4.40
3.87
13.70%
PATM
9.93%
13.89%
10.75%
7.22%
10.20%
6.59%
7.35%
7.52%
EPS
0.08
0.09
-11.11%
0.07
0.04
75.00%
0.07
0.04
75.00%
0.05
0.04
25.00%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
263.39
224.25
219.66
184.82
183.90
173.39
151.29
114.95
Net Sales Growth
17.45%
2.09%
18.85%
0.50%
6.06%
14.61%
31.61%
 
Cost Of Goods Sold
156.88
100.65
105.70
102.80
106.54
116.00
101.72
77.54
Gross Profit
106.51
123.60
113.96
82.03
77.36
57.40
49.57
37.41
GP Margin
40.44%
55.12%
51.88%
44.38%
42.07%
33.10%
32.76%
32.54%
Total Expenditure
233.74
204.35
199.63
168.27
167.23
155.18
135.02
104.30
Power & Fuel Cost
-
5.31
4.38
3.01
2.69
2.76
2.40
1.93
% Of Sales
-
2.37%
1.99%
1.63%
1.46%
1.59%
1.59%
1.68%
Employee Cost
-
24.44
20.73
14.45
13.48
13.38
11.35
10.06
% Of Sales
-
10.90%
9.44%
7.82%
7.33%
7.72%
7.50%
8.75%
Manufacturing Exp.
-
44.08
36.93
26.74
27.01
1.55
1.03
0.64
% Of Sales
-
19.66%
16.81%
14.47%
14.69%
0.89%
0.68%
0.56%
General & Admin Exp.
-
15.02
14.06
8.86
8.36
7.54
6.60
6.58
% Of Sales
-
6.70%
6.40%
4.79%
4.55%
4.35%
4.36%
5.72%
Selling & Distn. Exp.
-
14.29
17.32
12.09
8.90
13.72
11.84
7.47
% Of Sales
-
6.37%
7.88%
6.54%
4.84%
7.91%
7.83%
6.50%
Miscellaneous Exp.
-
0.56
0.50
0.31
0.26
0.23
0.08
0.08
% Of Sales
-
0.25%
0.23%
0.17%
0.14%
0.13%
0.05%
0.07%
EBITDA
29.65
19.90
20.03
16.55
16.67
18.21
16.27
10.65
EBITDA Margin
11.26%
8.87%
9.12%
8.95%
9.06%
10.50%
10.75%
9.26%
Other Income
13.53
14.60
11.99
2.79
2.67
1.98
1.12
1.15
Interest
4.47
3.40
1.93
0.33
0.14
0.29
0.47
0.52
Depreciation
4.73
4.54
3.95
3.12
3.00
3.40
2.99
2.83
PBT
33.95
26.56
26.15
15.89
16.20
16.49
13.93
8.45
Tax
8.65
6.50
6.39
5.34
5.75
5.88
4.61
2.79
Tax Rate
25.48%
24.46%
24.42%
33.63%
35.71%
37.62%
33.09%
33.02%
PAT
25.31
20.07
19.79
10.53
10.36
9.76
9.32
5.66
PAT before Minority Interest
25.31
20.07
19.79
10.53
10.36
9.76
9.32
5.66
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
9.61%
8.95%
9.01%
5.70%
5.63%
5.63%
6.16%
4.92%
PAT Growth
26.05%
1.41%
87.94%
1.64%
6.15%
4.72%
64.66%
 
EPS
0.27
0.21
0.21
0.11
0.11
0.10
0.10
0.06

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
256.01
222.22
117.35
108.70
100.22
95.20
87.71
Share Capital
94.00
86.25
78.07
78.07
78.07
78.07
22.30
Total Reserves
162.01
130.94
39.29
30.63
22.16
17.13
65.40
Non-Current Liabilities
8.66
7.76
7.73
6.27
5.62
6.81
8.28
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.69
1.71
0.00
0.00
0.00
0.00
0.00
Current Liabilities
113.16
78.26
58.84
65.69
36.66
41.62
28.50
Trade Payables
20.45
13.79
32.27
46.94
19.92
29.35
19.43
Other Current Liabilities
6.91
2.83
5.84
3.67
1.63
0.86
1.72
Short Term Borrowings
83.18
57.79
12.45
5.62
6.08
3.30
2.05
Short Term Provisions
2.62
3.85
8.27
9.46
9.04
8.11
5.30
Total Liabilities
377.83
308.24
183.92
180.66
142.50
143.63
124.49
Net Block
43.40
46.61
55.04
45.85
45.78
50.26
50.47
Gross Block
101.92
100.68
91.98
82.41
80.43
77.18
74.40
Accumulated Depreciation
58.53
54.07
36.94
36.56
34.65
26.93
23.93
Non Current Assets
196.14
168.44
97.38
88.99
58.91
65.54
62.50
Capital Work in Progress
25.59
6.20
0.25
4.72
0.00
0.00
0.00
Non Current Investment
1.84
1.93
35.91
23.37
6.38
9.31
6.74
Long Term Loans & Adv.
2.26
2.25
6.18
15.05
6.75
5.97
5.29
Other Non Current Assets
75.73
64.33
0.00
0.00
0.00
0.00
0.00
Current Assets
181.69
139.80
86.54
91.66
83.59
78.09
61.99
Current Investments
62.26
41.40
0.00
0.00
0.00
0.00
0.00
Inventories
21.20
19.51
10.01
15.47
10.94
9.90
6.07
Sundry Debtors
75.51
67.55
45.99
46.00
31.16
29.42
28.94
Cash & Bank
8.63
0.39
6.52
5.69
6.77
5.28
3.76
Other Current Assets
14.09
2.73
10.50
8.41
34.72
33.50
23.22
Short Term Loans & Adv.
9.63
8.23
13.52
16.10
25.47
27.63
17.28
Net Current Assets
68.53
61.54
27.70
25.98
46.93
36.47
33.49
Total Assets
377.83
308.24
183.92
180.65
142.50
143.63
124.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
10.53
16.33
13.84
24.07
0.08
6.73
5.78
PBT
26.56
26.15
15.88
16.10
16.49
13.93
8.45
Adjustment
-6.11
-7.16
0.71
1.14
2.59
2.36
2.24
Changes in Working Capital
-3.26
3.58
1.29
12.29
-12.51
-5.54
-2.58
Cash after chg. in Working capital
17.18
22.58
17.88
29.53
6.58
10.76
8.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.65
-6.25
-4.03
-5.35
-5.64
-4.02
-2.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
-0.01
-0.10
-0.86
0.00
0.00
Cash From Investing Activity
-44.95
-27.07
-17.68
-22.74
0.74
-4.28
-0.32
Net Fixed Assets
-20.63
-14.65
-5.10
-6.70
-3.25
-2.78
Net Investments
-20.80
-12.37
-7.49
-16.99
2.83
-2.57
Others
-3.52
-0.05
-5.09
0.95
1.16
1.07
Cash from Financing Activity
35.00
8.29
4.67
-2.40
0.68
-0.93
-6.38
Net Cash Inflow / Outflow
0.58
-2.45
0.83
-1.08
1.50
1.52
-0.92
Opening Cash & Equivalents
0.30
2.75
5.69
6.77
5.28
3.76
4.68
Closing Cash & Equivalent
0.88
0.30
6.52
5.69
6.77
5.28
3.76

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
2.72
2.52
1.50
1.39
1.28
1.22
1.12
ROA
5.85%
8.04%
5.78%
6.41%
6.82%
6.95%
4.54%
ROE
8.48%
11.83%
9.32%
9.91%
9.99%
10.19%
6.45%
ROCE
9.68%
13.72%
13.28%
14.72%
15.55%
15.29%
10.00%
Fixed Asset Turnover
2.21
2.28
2.12
2.28
2.20
2.00
1.55
Receivable days
116.42
94.33
90.83
75.88
63.71
70.22
91.86
Inventory Days
33.13
24.52
25.15
25.97
21.92
19.22
19.28
Payable days
62.08
79.52
91.28
73.89
59.55
67.54
70.98
Cash Conversion Cycle
87.47
39.33
24.70
27.96
26.08
21.90
40.17
Total Debt/Equity
0.32
0.27
0.11
0.05
0.06
0.03
0.02
Interest Cover
8.81
14.58
48.48
119.10
54.58
30.75
17.10

News Update:


  • Syncom Formulations - Quarterly Results
    17th May 2024, 18:42 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.